PACS
PACS Group, Inc.
NYSE · USFinancial ServicesFinancial - Conglomerates
$44.73-3.03%
Price as of Jul 20, 2026
PACS growth
PACS Group, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +20.9%
- EBITDA
- +117.2%
- EBIT
- +165.3%
- EPS
- +246.8%
- Free cash flow
- -14.3%
- Operating cash flow
- +6.9%
Forward estimates
- Revenue
- +9.0%
- EBITDA
- +2.0%
- EPS
- +38.1%
Three-year CAGR
- Revenue
- +29.7%
- EBITDA
- +12.8%
- EBIT
- +10.5%
- Net income
- +8.4%
- EPS
- +7.1%
- Free cash flow
- +62.4%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.